How to deal with target's company's non-controlling interest in a M&A scenario

Not sure if this is posted anywhere, but my question is as follows

Say Company A acquires 100% of Company B, on Company's B's book, there is a NCI item (which means, B consolidates a company without owning the majority interest of it).

  1. When B is being acquired, understand that B's assets & liabilities are valued at fair value. Is B's NCI also valued at fair value? How is this done?

  2. When calculating the transaction goodwill, if B's NCI does indeed valued at fair value, I have read somewhere that the calculations is as follows, is this correct?

Purchase price + FV of B's NCI - BV of B's net assets + B's goodwill write-off = Total allocable purchase price - write-ups of identifiable assets + write-ups of identifiable liabilities - DTA created + DTL created = Transaction goodwill

  1. When you are adjusting the balance sheet from before close to after close, would you be wiping off the entire common equities of B, while keeping B's NCI in the book (and write-up B's NCI to its FV)?

Thanks

2 Comments
 

Love how only actual analysts could answer this question. Given that majority of kids on here are college, you may not get a knowledgable answer. I hope you do

Haters gonna hate
 

Quisquam officiis in sapiente dolorem consequatur aliquid est in. Excepturi nihil id doloremque vero earum exercitationem. Et aspernatur dolore cum unde sed blanditiis distinctio.

Impedit libero dignissimos unde numquam sint. Occaecati veniam voluptatum eligendi dolor distinctio. Fugiat soluta deserunt ex sapiente magnam ab non. Ut dolor aut corrupti modi. Quasi voluptatem reprehenderit quo voluptatem.

Distinctio maxime facilis et id rem quam aspernatur. Dolores temporibus perferendis asperiores harum nulla facere esse. Quaerat ut iure dicta qui omnis. Molestiae qui accusamus consequatur soluta odit eaque. Ab quo nostrum libero modi doloribus qui quisquam. Quia facere recusandae impedit nesciunt eveniet esse impedit.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”